Drug Profile
Research programme: genetically engineered proteins - SK Chemicals
Alternative Names: Recombinant Factor 2 - SK Chemicals; Recombinant Factor 3 - SK ChemicalsLatest Information Update: 28 Apr 2018
Price :
$50
*
At a glance
- Originator SK Chemicals
- Class Blood coagulation factors; Recombinant proteins
- Mechanism of Action Blood coagulation modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Haemophilia
Most Recent Events
- 28 Apr 2018 No recent reports of development identified for preclinical development in Haemophilia in South Korea
- 17 Mar 2014 Preclinical trials in Haemophilia in South Korea (unspecified route)